Arasteh K

Savoirs

Treatment of HIV-related primary central nervous system lymphoma with azt high dose, HAART, interleukin-2 and foscarnet in three patients

Marretta L, Drauz D, Stocker H, Masuhr A, Dieckmann S, Wong V, Koch A, Grueneisen A, Weiss R, Mueller M, Arasteh K

Savoirs

Switch from a ZDV/3TC-based regimen to a completely once daily (QD) regimen of emtricitabine/tenofovir DF fixed dose combination plus a third QD agent (SONETT)

Arasteh K, Weitner L, Fenske S, Kuhlmann B, Freiwald M, Ebrahimi R, Gallo L, Ranneberg B, Mertenskoetter, Mertenskoetter T